Cargando…
The Prevalence of Selected Potential Drug-Drug Interactions of Analgesic Drugs and Possible Methods of Preventing Them: Lessons Learned From the Analysis of the Real-World National Database of 38 Million Citizens of Poland
Introduction: Drug-drug interactions may lead to poor health outcomes, as well as increased costs and utilization of healthcare services. Unfortunately, real-world data continuously prove high prevalence of potential drug-drug interactions (pDDIs) worldwide. Among identified drivers, ageing, multimo...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849760/ https://www.ncbi.nlm.nih.gov/pubmed/33536918 http://dx.doi.org/10.3389/fphar.2020.607852 |
_version_ | 1783645357477986304 |
---|---|
author | Kardas, Przemysław Urbański, Filip Lichwierowicz, Aneta Chudzyńska, Ewa Czech, Marcin Makowska, Katarzyna Kardas, Grzegorz |
author_facet | Kardas, Przemysław Urbański, Filip Lichwierowicz, Aneta Chudzyńska, Ewa Czech, Marcin Makowska, Katarzyna Kardas, Grzegorz |
author_sort | Kardas, Przemysław |
collection | PubMed |
description | Introduction: Drug-drug interactions may lead to poor health outcomes, as well as increased costs and utilization of healthcare services. Unfortunately, real-world data continuously prove high prevalence of potential drug-drug interactions (pDDIs) worldwide. Among identified drivers, ageing, multimorbidity and polypharmacy play a very important role. With these factors being widespread, the need for implementation of strategies minimizing the burden of pDDIs becomes an urgency. This, however, requires a better understanding of the prevalence of pDDIs and the underlying causative factors. Aim of study: To assess the real-world prevalence of pDDIs and its characteristics in the general population of Poland, using analgesic drugs as a model, and to find out whether pDDIs are caused by prescribing coming from the very same prescribers (co-prescribing). Methods: A retrospective analysis of the 2018 dispensation data of the National Health Fund (NHF) - the only Polish public healthcare payer organization with nationwide coverage. We searched for selected pDDIs of non-steroidal anti-inflammatory drugs (NSAIDs) with antihypertensives, other NSAIDs (double use), oral glucocorticoids, oral anticoagulants, selective serotonin reuptake inhibitors (SSRIs), serotonin–norepinephrine reuptake inhibitors (SNRIs), and antiplatelet drugs; as well as opioides with SSRIs, SNRIs, gabapentinoids, and benzodiazepines. A pDDI was deemed present if two drugs standing in a possible conflict were dispensed within the same calendar month. Results: Out of 38.4 million citizens of Poland, 23.3 million were dispensed prescribed drugs reimbursed by NHF in 2018. In this cohort, we have identified 2,485,787 cases of analgesic drug pDDIs, corresponding with 6.47% of the Polish population. Out of these, the most prevalent pDDI was caused by “NSAIDs + antihypertensives” (1,583,575 cases, i.e., 4.12% of the Polish population), followed by “NSAIDs + NSAIDs” (538,640, 1.40%) and “NSAIDs + glucocorticoids” (213,504, 0.56%). The most persistent pDDIs among those studied were caused by “Opioids + Gabapentinoids” (2.19, 95%CI: 2.16–2.22 months). On average, 76.63% of all cases of pDDIs were caused by drugs prescribed by the very same prescribers. Conclusion: Based on high-quality, nationwide data, we have found a high prevalence of analgesic drugs-related pDDIs in Poland. Over ¾ of the identified pDDIs were caused by co-prescribing, i.e., prescriptions issued by the same prescribers. The significance of the problem, illustrated with our findings on analgesic drugs-related pDDIs in Poland, deserves much more scientific and policymaker attention. |
format | Online Article Text |
id | pubmed-7849760 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78497602021-02-02 The Prevalence of Selected Potential Drug-Drug Interactions of Analgesic Drugs and Possible Methods of Preventing Them: Lessons Learned From the Analysis of the Real-World National Database of 38 Million Citizens of Poland Kardas, Przemysław Urbański, Filip Lichwierowicz, Aneta Chudzyńska, Ewa Czech, Marcin Makowska, Katarzyna Kardas, Grzegorz Front Pharmacol Pharmacology Introduction: Drug-drug interactions may lead to poor health outcomes, as well as increased costs and utilization of healthcare services. Unfortunately, real-world data continuously prove high prevalence of potential drug-drug interactions (pDDIs) worldwide. Among identified drivers, ageing, multimorbidity and polypharmacy play a very important role. With these factors being widespread, the need for implementation of strategies minimizing the burden of pDDIs becomes an urgency. This, however, requires a better understanding of the prevalence of pDDIs and the underlying causative factors. Aim of study: To assess the real-world prevalence of pDDIs and its characteristics in the general population of Poland, using analgesic drugs as a model, and to find out whether pDDIs are caused by prescribing coming from the very same prescribers (co-prescribing). Methods: A retrospective analysis of the 2018 dispensation data of the National Health Fund (NHF) - the only Polish public healthcare payer organization with nationwide coverage. We searched for selected pDDIs of non-steroidal anti-inflammatory drugs (NSAIDs) with antihypertensives, other NSAIDs (double use), oral glucocorticoids, oral anticoagulants, selective serotonin reuptake inhibitors (SSRIs), serotonin–norepinephrine reuptake inhibitors (SNRIs), and antiplatelet drugs; as well as opioides with SSRIs, SNRIs, gabapentinoids, and benzodiazepines. A pDDI was deemed present if two drugs standing in a possible conflict were dispensed within the same calendar month. Results: Out of 38.4 million citizens of Poland, 23.3 million were dispensed prescribed drugs reimbursed by NHF in 2018. In this cohort, we have identified 2,485,787 cases of analgesic drug pDDIs, corresponding with 6.47% of the Polish population. Out of these, the most prevalent pDDI was caused by “NSAIDs + antihypertensives” (1,583,575 cases, i.e., 4.12% of the Polish population), followed by “NSAIDs + NSAIDs” (538,640, 1.40%) and “NSAIDs + glucocorticoids” (213,504, 0.56%). The most persistent pDDIs among those studied were caused by “Opioids + Gabapentinoids” (2.19, 95%CI: 2.16–2.22 months). On average, 76.63% of all cases of pDDIs were caused by drugs prescribed by the very same prescribers. Conclusion: Based on high-quality, nationwide data, we have found a high prevalence of analgesic drugs-related pDDIs in Poland. Over ¾ of the identified pDDIs were caused by co-prescribing, i.e., prescriptions issued by the same prescribers. The significance of the problem, illustrated with our findings on analgesic drugs-related pDDIs in Poland, deserves much more scientific and policymaker attention. Frontiers Media S.A. 2021-01-18 /pmc/articles/PMC7849760/ /pubmed/33536918 http://dx.doi.org/10.3389/fphar.2020.607852 Text en Copyright © 2021 Kardas, Urbański, Lichwierowicz, Chudzyńska, Czech, Makowska and Kardas. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (http://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Kardas, Przemysław Urbański, Filip Lichwierowicz, Aneta Chudzyńska, Ewa Czech, Marcin Makowska, Katarzyna Kardas, Grzegorz The Prevalence of Selected Potential Drug-Drug Interactions of Analgesic Drugs and Possible Methods of Preventing Them: Lessons Learned From the Analysis of the Real-World National Database of 38 Million Citizens of Poland |
title | The Prevalence of Selected Potential Drug-Drug Interactions of Analgesic Drugs and Possible Methods of Preventing Them: Lessons Learned From the Analysis of the Real-World National Database of 38 Million Citizens of Poland |
title_full | The Prevalence of Selected Potential Drug-Drug Interactions of Analgesic Drugs and Possible Methods of Preventing Them: Lessons Learned From the Analysis of the Real-World National Database of 38 Million Citizens of Poland |
title_fullStr | The Prevalence of Selected Potential Drug-Drug Interactions of Analgesic Drugs and Possible Methods of Preventing Them: Lessons Learned From the Analysis of the Real-World National Database of 38 Million Citizens of Poland |
title_full_unstemmed | The Prevalence of Selected Potential Drug-Drug Interactions of Analgesic Drugs and Possible Methods of Preventing Them: Lessons Learned From the Analysis of the Real-World National Database of 38 Million Citizens of Poland |
title_short | The Prevalence of Selected Potential Drug-Drug Interactions of Analgesic Drugs and Possible Methods of Preventing Them: Lessons Learned From the Analysis of the Real-World National Database of 38 Million Citizens of Poland |
title_sort | prevalence of selected potential drug-drug interactions of analgesic drugs and possible methods of preventing them: lessons learned from the analysis of the real-world national database of 38 million citizens of poland |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849760/ https://www.ncbi.nlm.nih.gov/pubmed/33536918 http://dx.doi.org/10.3389/fphar.2020.607852 |
work_keys_str_mv | AT kardasprzemysław theprevalenceofselectedpotentialdrugdruginteractionsofanalgesicdrugsandpossiblemethodsofpreventingthemlessonslearnedfromtheanalysisoftherealworldnationaldatabaseof38millioncitizensofpoland AT urbanskifilip theprevalenceofselectedpotentialdrugdruginteractionsofanalgesicdrugsandpossiblemethodsofpreventingthemlessonslearnedfromtheanalysisoftherealworldnationaldatabaseof38millioncitizensofpoland AT lichwierowiczaneta theprevalenceofselectedpotentialdrugdruginteractionsofanalgesicdrugsandpossiblemethodsofpreventingthemlessonslearnedfromtheanalysisoftherealworldnationaldatabaseof38millioncitizensofpoland AT chudzynskaewa theprevalenceofselectedpotentialdrugdruginteractionsofanalgesicdrugsandpossiblemethodsofpreventingthemlessonslearnedfromtheanalysisoftherealworldnationaldatabaseof38millioncitizensofpoland AT czechmarcin theprevalenceofselectedpotentialdrugdruginteractionsofanalgesicdrugsandpossiblemethodsofpreventingthemlessonslearnedfromtheanalysisoftherealworldnationaldatabaseof38millioncitizensofpoland AT makowskakatarzyna theprevalenceofselectedpotentialdrugdruginteractionsofanalgesicdrugsandpossiblemethodsofpreventingthemlessonslearnedfromtheanalysisoftherealworldnationaldatabaseof38millioncitizensofpoland AT kardasgrzegorz theprevalenceofselectedpotentialdrugdruginteractionsofanalgesicdrugsandpossiblemethodsofpreventingthemlessonslearnedfromtheanalysisoftherealworldnationaldatabaseof38millioncitizensofpoland AT kardasprzemysław prevalenceofselectedpotentialdrugdruginteractionsofanalgesicdrugsandpossiblemethodsofpreventingthemlessonslearnedfromtheanalysisoftherealworldnationaldatabaseof38millioncitizensofpoland AT urbanskifilip prevalenceofselectedpotentialdrugdruginteractionsofanalgesicdrugsandpossiblemethodsofpreventingthemlessonslearnedfromtheanalysisoftherealworldnationaldatabaseof38millioncitizensofpoland AT lichwierowiczaneta prevalenceofselectedpotentialdrugdruginteractionsofanalgesicdrugsandpossiblemethodsofpreventingthemlessonslearnedfromtheanalysisoftherealworldnationaldatabaseof38millioncitizensofpoland AT chudzynskaewa prevalenceofselectedpotentialdrugdruginteractionsofanalgesicdrugsandpossiblemethodsofpreventingthemlessonslearnedfromtheanalysisoftherealworldnationaldatabaseof38millioncitizensofpoland AT czechmarcin prevalenceofselectedpotentialdrugdruginteractionsofanalgesicdrugsandpossiblemethodsofpreventingthemlessonslearnedfromtheanalysisoftherealworldnationaldatabaseof38millioncitizensofpoland AT makowskakatarzyna prevalenceofselectedpotentialdrugdruginteractionsofanalgesicdrugsandpossiblemethodsofpreventingthemlessonslearnedfromtheanalysisoftherealworldnationaldatabaseof38millioncitizensofpoland AT kardasgrzegorz prevalenceofselectedpotentialdrugdruginteractionsofanalgesicdrugsandpossiblemethodsofpreventingthemlessonslearnedfromtheanalysisoftherealworldnationaldatabaseof38millioncitizensofpoland |